The Menopause Visual Analogue Scale: a new tool for measuring the severity and response to treatment of symptoms throughout the menopausal transition

Menopause

Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life

Menopause.

Hildreth KL, Ozemek C, Kohrt WM, Blatchford PJ, Moreau KL

Lower Urinary Tract Symptoms

The Comprehensive Assessment of Self-Reported Urinary Symptoms (CASUS): A New Tool for Research on Subtypes of Patients with Lower Urinary Tract Symptoms

J Urol.

Weinfurt KP, Griffith JW, Flynn KE, Cella D, Bavendam T, Wiseman JB, Andreev VP, Lai HH, Liu AB, Kirkali Z, Cameron AP, Bradley CS; LURN Study Group

doi: 10.1097/JU.

Menopause

Onset of the Menopause Transition: The Earliest Signs and Symptoms

Obstet Gynecol Clin North Am.

Gracia CR, Freeman EW

doi: 10.1016/j.ogc.2018.07.002.

Menopause

Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial

JAMA Psychiatry.

Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS

doi: 10.1001/

Erectile and Sexual Functions and DysfunctionsMenopause

CO2 LASER for the treatment of vaginal symptoms of genitourinary syndrome of menopause

Gynecol Obstet Fertil Senol.

Jardin I, Canlorbe G, Mergui JL, Nikpayam M, Belghiti J, Uzan C, Azaïs H

doi: 10.1016/j.gofs.2018.09.001.

Menopause

Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause

Lasers Surg Med.

Gaspar A, Brandi H, Gomez V, Luque D

doi: 10.1002/lsm.22569.

Menopause

Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial

Menopause.

Hattersley G, Harris AG, Simon JA, Constantine GD

doi: 10.1097/

Menopause

Linking the menopause rating scale to the International classification of functioning, disability and health - A first step towards the implementation of the EMAS menopause health care model

Maturitas.

Zangger M, Poethig D, Meissner F, von Wolff M, Stute P

doi: 10.1016/j.maturitas.

Menopause

The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review

Menopause.

Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, Pinkerton JV, Stuenkel CA, Traish AM, Archer DF, Bachmann G, Goldstein AT, Nappi RE, Vignozzi L

doi: 10.1097/

Related content

Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life

The Comprehensive Assessment of Self-Reported Urinary Symptoms (CASUS): A New Tool for Research on Subtypes of Patients with Lower Urinary Tract Symptoms

Onset of the Menopause Transition: The Earliest Signs and Symptoms

Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial

CO2 LASER for the treatment of vaginal symptoms of genitourinary syndrome of menopause

Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause

Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial

Linking the menopause rating scale to the International classification of functioning, disability and health - A first step towards the implementation of the EMAS menopause health care model

The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review